Acute regression of a melanocytic neoplasm.

J Cutan Pathol

Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Published: October 2023

Immune-mediated regression of melanocytic neoplasms is predominantly lymphocytic, driven by CD8+ anti-tumoral T-cells and, rarely, natural killer cells. Histopathologic features of regression include effacement of the epidermis, replacement of tumor cells by a fibrotic stroma, varying degrees of chronic inflammation (usually lymphocytes) and melanophages, as well as vascular ectasia and angioplasia. The understanding of regression and the complex immune response in melanoma has led to the development of targeted immunotherapy in melanoma. Here, we report a case of near-complete regression of a melanocytic neoplasm associated with neutrophilic and eosinophilic inflammation, suggesting a non-traditional pathway of regression that has yet to be explored.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.14492DOI Listing

Publication Analysis

Top Keywords

regression melanocytic
12
melanocytic neoplasm
8
regression
5
acute regression
4
neoplasm immune-mediated
4
immune-mediated regression
4
melanocytic neoplasms
4
neoplasms lymphocytic
4
lymphocytic driven
4
driven cd8+
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!